Zhang T., Zhang Y., Tu S., Wu Y., Zhang Z., and Meng F., Design, Synthesis and Biological Evaluation of N(3(1HTetrazol1Yl)Phenyl)Isonicotinamide Derivatives as Novel Xanthine Oxidase Inhibitors, European Journal of Medicinal Chemistry 183 (2019): 111717, 10.1016/j.ejmech.2019.111717
We also observed an increase in the 18 kDa translocator protein TSPO, which is a mitochondrial cholesterol-binding protein and upregulated in microglia during inflammatory activation associated with neurodegeneration (Fig
December Dec 26: Accelerated approval doesnt always equal full clearance, something Amgen was reminded of when the FDA declined to convert Lumakras May 2021 conditional nod in KRASG12C-mutated non-small cell lung cancer (NSCLC) to a traditional one
It remains an investigational compound in Phase 3 clinical development